LaRed

International Clinical Research Networks Forum – A Collaborative Approach for Pandemic Preparedness and Response

by

Objectives

  • Discuss how clinical research networks can be leveraged for public health emergency/pandemic preparedness and response.
  • Prepare clinical research networks for international collaboration during future preparedness and response efforts based on recent lessons learned from COVID-19 and other infectious disease outbreaks.
  • Expand existing and create new collaborative research networking opportunities.

International Clinical Research Networks Forum conference logo

For each of the below presentations, click on the language of your preference: English (Eng), Spanish (Spa), French (Fre), Bahasa (Bah).

Welcoming Remarks and Introduction

Dr. Maria Julia Marinissen – Health Attaché, HHS-US Embassy.

Dr. Abelardo Montenegro – Manager, LaRed Coordinating Center.

(Eng), (Spa), (Fre), (Bah)

Keynote Remarks

Ken L. Salazar – US Ambassador to Mexico.

(Eng), (Spa), (Fre), (Bah)

Dr. Hugo López-Gatell – Mexico Undersecretary of Health.

Dr. William Lee Alardin – Coordinator of Scientific Research, National Autonomous University of Mexico in representation of Dr. Enrique Graue Wiechers, Rector.

Dr. Anthony Fauci (video message) – Director, National Institute of Allergy, and Infectious Diseases.

Session I – Rapid Response Approaches

Epidemiology of Infectious Diseases in Mexico and Evolution of LaRed

Speaker: Dr. Guillermo Ruiz-Palacios – National Institute of Medical Sciences and Nutrition Salvador Zubirán.

(Eng), (Spa), (Fre), (Bah)

Partnerships Across the Globe; DCR Networks Addressing Emergent Infectious Diseases

Speaker: Dr. Clifford H. Lane – Director, Division of Clinical Research, National Institute of Allergy, and Infectious Diseases

(Eng), (Spa), (Fre), (Bah)

Session II – Policy in a Rapid Response Environment

Policy and Considerations for Rapid Clinical Research during Pandemic Responses

Speaker: Dr. Hugo López-Gatell – Deputy Secretariat of Health. – Deputy Secretariat of Health.

(Eng), (Spa), (Fre), (Bah)

Regulatory Certainty

Speaker: Dr. Alejandro Svarch Pérez – Commissioner, COFEPRIS.

(Eng), (Spa), (Fre), (Bah)

Session III – Diagnostics Development and Facing Multiple Outbreaks Simultaneously

Diagnostic Testing Developments – Pathogens, Discovery, and New Technologies

Speaker: Dr. Ian Lipkin – John Snow Professor of Epidemiology Chair; Columbia School of Public Health – Director, Global Alliance for Pandemic Prevention (GAPP).

(Eng), (Spa), (Fre), (Bah)

Approaches to Competing Pandemics; Balancing Multiple Diseases at Once

Speaker: Dr. Olivier Tshiani in representation of Dr. Jean-Jacques Muyembe-Tamfum – General Director of the Democratic Republic of the Congo Institute National pour la Reserche Biomedicale (INRB).

(Eng), (Spa), (Fre), (Bah)

Session IV: Vaccine Development

Evolution and dynamics of SARS-CoV-2 variants in Mexico

Speaker: Dr. Carlos Federico Arias Ortíz – Institute of Biotechnology, National Autonomous University of Mexico.

(Eng), (Spa), (Fre), (Bah)

The Evaluation of the Efficiency of the Vaccines used in Mexico

Speaker: Dr. Mauricio Hernández Avila – Director of Economic and Social Benefits, IMSS.

(Eng), (Spa), (Fre), (Bah)

Session V – Therapeutic & Observational Study Designs and Key Aspects of Regional Collaborations

Master Adaptive Protocol Design – ACTT

Speaker: Dr. John Beigel – Associate Director for Clinical Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy, and Infectious Disease.

(Eng), (Spa), (Fre), (Bah)

Global Observational Studies Development and Implementation

Speaker: Dr. Sally Hunsberger – Biostatistician, NIAID.

(Eng), (Spa), (Fre), (Bah)

Regional Collaborations in W. Africa

Speaker: Dr. Stephen Kennedy – Co-Chair, West Africa Consortium (WAC).

(Eng), (Spa), (Fre), (Bah)

Closing remarks

Dr. Guillermo Ruiz-Palacios – National Institute of Medical Sciences and Nutrition Salvador Zubirán.

(Eng), (Spa), (Fre), (Bah)

Dr. Clifford H. Lane – Director, Division of Clinical Research, National Institute of Allergy, and Infectious Diseases.